PLD1-driven oncogenic secretion creates a therapeutic vulnerability in chromosome 3q–amplified NSCLC
Proceedings of the National Academy of Sciences, Volume 123, Issue 43, October 2026. SignificanceChromosome 3q–amplified non–small cell lung cancer (3q-NSCLC) represents an aggressive and therapeutically challenging subtype.